NIH-funded research NIH-funded research

Gastrointestinal Cancer SPORE at Vanderbilt-Ingram Cancer Center

Official title: Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal Cancer

Funded at Vanderbilt University Medical Center · NIH-11393790 · Data updated 2026-11-12

A multi-year NIH grant supports focused work on colorectal cancer at Vanderbilt with emphasis on collaborative research, resources, and patient advocacy to accelerate discoveries and potential treatments.

More Gastrointestinal Cancer research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startJuly 9, 2019
Project endJuly 31, 2030
Funding year2026
Award (this year)$2,317,951
NIH project number5P50CA236733-07
Project IDNIH-11393790 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with colorectal cancer or those at high risk, who may participate through future translational studies, clinical trials, or biospecimen contributions.

Less likely to help

Patients without colorectal cancer or without eligibility for related translational studies may not directly benefit.

What this research studies

This grant funds a team at Vanderbilt to pursue translational GI cancer research centered on colorectal cancer, leveraging existing resources, a mix of clinical and basic scientists, and strong institutional support. It includes career development for investigators and dedicated cores for data, bioinformatics, biostatistics, and drug discovery using ex vivo models. Patient advocates are actively involved through a formal council to guide research priorities and ensure patient needs are considered. The program emphasizes collaborations across SPOREs, industry partners, and international groups to accelerate progress toward better prevention, diagnosis, and treatment.

Why it matters

Potential benefit: If successful, this work could lead to new therapeutic strategies and improved outcomes for people affected by colorectal cancer.

How similar studies have gone: Previous GI SPORE efforts have demonstrated productive collaborations and tangible advances, with strong institutional backing and interconnected research activities.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Coffey, Robert J. — Vanderbilt University Medical Center
  • Study coordinator: Coffey, Robert J.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.